These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1363760)

  • 1. [Absence of correlation between morphometric parameters and C-erb-B2 positivity].
    Leopardi O; Colavecchio A; Colecchia M; Cannatelli G
    Pathologica; 1992; 84(1094):83-5. PubMed ID: 1363760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphometric evaluation and AgNOR number in c-erbB-2 positive and negative breast carcinoma: absence of correlation].
    Leopardi O; Caronni E; Zucchi A; Colecchia M; Dedé A
    Pathologica; 1993; 85(1096):163-73. PubMed ID: 8103213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of c-erb B-2 oncoprotein expression in female breast cancer and its prognostic significance.
    Tervahauta A; Eskelinen M; Syrjänen S; Lipponen P; Pajarinen P; Syrjänen K
    Anticancer Res; 1991; 11(5):1677-81. PubMed ID: 1685075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.
    Bhatavdekar JM; Patel DD; Sherbet GV; Giri DD; Karelia NH; Vora HH; Shah NG; Suthar TP; Nadkarni SP; Balar DB
    Eur J Surg Oncol; 1993 Oct; 19(5):409-13. PubMed ID: 8104829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH; Leslie KO; Rogers LA; Howard PL
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human breast cancer: prognostic significance of DNA ploidy compared with c-erbB2 expression, Cathepsin D and silver-binding nucleolar organizer regions (AgNORs).
    Borgiani L; Cogorno P; Buccaran G; Gallo L; Rovida S; Canepa M
    Pathologica; 1994 Aug; 86(4):350-5. PubMed ID: 7708434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measurement of C-erbB-2 protein in breast cancer tissue by enzyme-immunoassay: preliminary report].
    Narita T; Funahashi H; Sato Y; Imai T; Takagi H
    Nihon Geka Gakkai Zasshi; 1993 Jun; 94(6):661. PubMed ID: 8101962
    [No Abstract]   [Full Text] [Related]  

  • 10. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphological features, AgNOR counts and c-erb B-2 in carcinoma breast.
    Sinha SK; Singh UR; Bhatia A; Gupta S
    J Indian Med Assoc; 1998 Mar; 96(3):71-3, 76. PubMed ID: 9828547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
    Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M
    Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
    Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ras, c-myc and c-erbB-2 oncoproteins in human breast cancer.
    Spandidos DA; Yiagnisis M; Papadimitriou K; Field JK
    Anticancer Res; 1989; 9(5):1385-93. PubMed ID: 2574023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
    Hanna W; Kahn HJ; Andrulis I; Pawson T
    Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical tumor markers in infiltrating ductal breast carcinoma].
    Gallegos M; González S; León A; Claure R; Goñi I; Andrade L; Duarte I
    Rev Med Chil; 1998 Oct; 126(10):1216-23. PubMed ID: 10030093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-erb B-2 protein in the sera of breast cancer patients].
    Narita T; Funahashi H; Satoh Y; Takagi H
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):909-11. PubMed ID: 1351384
    [No Abstract]   [Full Text] [Related]  

  • 19. C-erbB-2 expression in squamous cell carcinoma of the head and neck.
    Field JK; Spandidos DA; Yiagnisis M; Gosney JR; Papadimitriou K; Stell PM
    Anticancer Res; 1992; 12(3):613-9. PubMed ID: 1377893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of oestrogen and progesterone receptors, and c-erbB-2 in carcinoma of the breast in Trinidadian women.
    Rao AV; Mohammed WA; Ragoonanan C; Omo-Igbinomwanhia NE
    West Indian Med J; 2002 Mar; 51(1):4-9. PubMed ID: 12089875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.